Great West Life Assurance CO Apellis Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

A detailed history of Great West Life Assurance CO transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 8,030 shares of APLS stock, worth $264,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,030
Previous 18,736 57.14%
Holding current value
$264,668
Previous $719,000 67.73%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$28.84 - $41.15 $308,761 - $440,551
-10,706 Reduced 57.14%
8,030 $232,000
Q2 2024

Aug 12, 2024
BUY
$38.07 - $59.71 $78,386 - $122,942
2,059 Added 12.35%
18,736 $719,000
Q1 2024

May 13, 2024
BUY
$55.39 - $72.47 $478,957 - $626,648
8,647 Added 107.68%
16,677 $981,000
Q4 2023

Feb 13, 2024
BUY
$37.14 - $64.82 $25,589 - $44,660
689 Added 9.39%
8,030 $478,000
Q3 2023

Nov 14, 2023
BUY
$23.65 - $89.22 $94,600 - $356,880
4,000 Added 119.72%
7,341 $279,000
Q2 2023

Aug 10, 2023
SELL
$76.68 - $93.31 $68,321 - $83,139
-891 Reduced 21.05%
3,341 $306,000
Q1 2023

May 12, 2023
SELL
$46.59 - $66.96 $13,324 - $19,150
-286 Reduced 6.33%
4,232 $280,000
Q4 2022

Feb 10, 2023
BUY
$43.24 - $61.04 $18,593 - $26,247
430 Added 10.52%
4,518 $235,000
Q3 2022

Nov 01, 2022
BUY
$44.76 - $69.66 $182,978 - $284,770
4,088 New
4,088 $278,000
Q1 2022

May 12, 2022
BUY
$35.46 - $54.12 $17,730 - $27,060
500 Added 15.46%
3,734 $202,000
Q2 2021

Aug 11, 2021
SELL
$40.9 - $64.9 $32,229 - $51,141
-788 Reduced 19.59%
3,234 $204,000
Q3 2020

Nov 17, 2020
BUY
$25.89 - $33.65 $97,812 - $127,129
3,778 Added 1548.36%
4,022 $121,000
Q3 2020

Nov 13, 2020
SELL
$25.89 - $33.65 $278,058 - $361,401
-10,740 Reduced 97.78%
244 $7,000
Q2 2020

Aug 17, 2020
BUY
$24.8 - $38.49 $204,401 - $317,234
8,242 Added 300.58%
10,984 $357,000
Q4 2019

Feb 11, 2020
BUY
$22.1 - $30.8 $60,598 - $84,453
2,742 New
2,742 $83,000
Q3 2019

Oct 25, 2019
SELL
$24.09 - $32.18 $144,660 - $193,240
-6,005 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$16.57 - $21.03 $99,502 - $126,285
6,005 New
6,005 $107,000

Others Institutions Holding APLS

# of Institutions
308
Shares Held
115M
Call Options Held
3.85M
Put Options Held
1.09M
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.62B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email